Inaction over retractions of identified fraudulent publications: ongoing weakness in the system of scientific self-correction

Accountability in Research

Volumn 25, Issue 4, 2018, Pages 239-253

  Wiedermann, Christian J ^a  

^a UMIT Private Universität für Medizinische Informatik und Technik   (Austria)

Author keywords

Authorship; misconduct in research; publication ethics; research ethics; retraction notice; science communication

Indexed keywords

HETASTARCH DERIVATIVE;

ETHICS; HUMAN; MEDICAL RESEARCH; PUBLICATION; PUBLISHING; SCIENTIFIC MISCONDUCT;

BIOMEDICAL RESEARCH; EDITORIAL POLICIES; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PERIODICALS AS TOPIC; RETRACTION OF PUBLICATION AS TOPIC; SCIENTIFIC MISCONDUCT;

EID: 85045922810     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989621.2018.1450143     Document Type: Review

References (30)

1. Allison, D. B., A. W., Brown, B. J., George, and K. A., Kaiser. 2016. Reproducibility: A tragedy of errors. Nature 530 (7588):27–29. doi:10.1038/530027a.
2. Antonelli, M., and C., Sandroni. 2013. Hydroxyethyl starch for intravenous volume replacement: More harm than benefit. Journal of the American Medical Association 309 (7):723–24. doi:10.1001/jama.2013.851.
3. Bar-Ilan, J., and G., Halevi. 2017. Post retraction citations in context: A case study. Scientometrics 113 (1):547–65. doi:10.1007/s11192-017-2242-0.
4. Boldt, J., S., Suttner, C., Brosch, A., Lehmann, K., Röhm, and A., Mengistu. 2009. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesthesia & Analgesia 109 (6):1752–62. doi:10.1213/ANE.0b013e3181b5a24b.
5. Cohen, D., 2018. EMA calls for hydroxyethyl starch solutions to be taken off market. BMJ (Clinical Research Ed.) 360:k225. doi:10.1136/bmj.k225.
6. Elia, N., E., Wager, M. R., Tramèr, and K. B., Wray. 2014. Fate of articles that warranted retraction due to ethical concerns: A descriptive cross-sectional study. PLoS ONE 9 (1):e85846. doi:10.1371/journal.pone.0085846.
7. EMA (European Medicines Agency). (2018a). PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market. EMA/4068/2018, January 12. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Hydroxyethyl_starch_107i/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500241325.pdf.
8. EMA (European Medicines Agency). (2018b). Hydroxyethyl-starch solutions for infusion to be suspended–CMDh endorses PRAC recommendation. EMA/35795/2018 corr. 1, January 26. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Hydroxyethyl_starch_107i/Position_provided_by_CMDh/WC500242407.pdf.
9. Fanelli, D., 2013. Why growing retractions are (mostly) a good sign. PLoS Medicine 10 (12):e1001563. doi:10.1371/journal.pmed.1001563.
10. Giraldo, Y., S., Almashat, S., Wolfe, M., Carome, C., Natanson, and I., Roberts (2017). Letter to the EMA urging a ban of hydroxyethyl starch solutions in Europe. Public Citizen, February 8. https://www.citizen.org/our-work/health-and-safety/letter-ema-urging-ban-hydroxyethyl-starch-solutions-europe.
11. Hoffart, J., A., Teichmann, and I., Wessler. 2011. biomedical research in Germany: The role of ethics committee and state medical association. Anesthesia & Analgesia 112 (3):501–03. doi:10.1213/ANE.0b013e31820acb75.
12. Houses of Parliament; Science and Technology Committee (Commons). (2017). Research integrity inquiry. Postnote 544, January. http://researchbriefings.files.parliament.uk/documents/POST-PN-0544/POST-PN-0544.pdf (accessed March 15, 2018).
13. Klinikum Ludwigshafen. (2010). Untersuchungsbericht der Kommission für die Pressekonferenz am 29. November 2010. November 29. https://www.klilu.de/content/veranstaltungen___presse/pressearchiv/2010/untersuchungsbericht_der_kommission_fuer_die_pressekonferenz_am_29_november_2010/index_ger.html.
14. Klinikum Ludwigshafen. (2012). Hospital presents results of final report: Committee completes investigation in the case of Dr Boldt. August 09. www.klilu.de/content/veranstaltungen___presse/pressearchiv/2012/hospital_presents_results_of_final_report_committee_completes_investigation_in_the_case_of_dr_boldt/index_ger.html.
15. Myburgh, J. A., S., Finfer, R., Bellomo, L., Billot, A., Cass, D., Gattas, P., Glass, J., Lipman, B., Liu, C., McArthur, et al. 2012. Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care. The New England Journal of Medicine 367 (20):1901–11. doi:10.1056/NEJMoa1209759.
16. Navickis, R. J., G. R., Haynes, and M. M., Wilkes. 2012. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials. The Journal of Thoracic and Cardiovascular Surgery 144 (1):223–30. doi:10.1016/j.jtcvs.2012.04.009.
17. No authors listed. 2011. Editors-in-chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. 2011. Minerva Anestesiol 77 (5):562–63.
18. Patel, A., M. A., Laffan, U., Waheed, and S. J., Brett. 2014. Randomised trials of human albumin for adults with sepsis: Systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ (Clinical Research Ed.) 349:g4561. doi:10.1136/bmj.g4561.
19. Perel, P., I., Roberts, and K., Ker. 2013. Colloids versus crystalloids for fluid resuscitation in critically ill patients (Review). Cochrane Database of Systematic Reviews 2:CD000567. doi:10.1002/14651858.CD000567.pub6.
20. Perner, A., N., Haase, A. B., Guttormsen, J., Tenhunen, G., Klemenzson, A., Åneman, K. R., Madsen, M. H., Møller, J. M., Elkjær, L. M., Poulsen, et al. 2012. Hydroxyethyl starch 130/0.42 versus ringer’s acetate in severe sepsis. The New England Journal of Medicine 367 (2):124–34. doi:10.1056/NEJMoa1204242.
21. Rhodes, A., L. E., Evans, W., Alhazzani, M. M., Levy, M., Antonelli, R., Ferrer, A., Kumar, J. E., Sevransky, C. L., Sprung, M. E., Nunnally, et al. 2017. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine 43 (3):304–77. doi:10.1007/s00134-017-4683-6.
22. Rochwerg, B., W., Alhazzani, A., Sindi, D., Heels-Ansdell, L., Thabane, A., Fox-Robichaud, L., Mbuagbaw, W., Szczeklik, F., Alshamsi, S., Altayyar, et al. 2014. Fluid resuscitation in sepsis: A systematic review and network meta-analysis. Annals of Internal Medicine 161 (5):347–55. doi:10.7326/M14-0178.
23. Shafer, S. L., 2010. Notice of Retraction. Anesthesia and Analgesia 111 (6):1567. doi:10.1213/ANE.0b013e3182040b99.
24. Shafer, S. L., 2011. Shadow of doubt. Anesthesia & Analgesia 112 (3):498–500. doi:10.1213/ANE.0b013e31820ad3b7.
25. Tramèr, M. R., 2013. The fujii story. A chronicle of naïve disbelief. European Journal of Anaesthesiology 30 (5):195–98. doi:10.1097/EJA.0b013e328360a0db.
26. U.S. NLM (National Library of Medicine). (2002). Fact sheet: Errata, retractions, and other linked citations in pubmed. March 06. http://www.nlm.nih.gov/pubs/factsheets/errata.html, accessed 12December 2017.
27. Wager, E., V., Barbour, S., Yentis, S., Kleiner, and COPE Council. (2009). COPE committee on publication ethics retraction guidelines. September. http://publicationethics.org/files/retraction%20guidelines_0.pdf (accessed March 15, 2018).
28. Wiedermann, C. J., 2016. Study citation irrespective of retraction status. Journal of Clinical Anesthesia 34:517. doi:10.1016/j.jclinane.2016.06.005.
29. Wiedermann, C. J., and K., Eisendle. 2017. Comparison of hydroxyethyl starch regulatory summaries from the food and drug administration and the European medicines agency. Journal of Pharmaceutical Policy and Practice 10:12. doi:10.1186/s40545-016-0090-6.
30. Zarychanski, R., A. M., Abou-Setta, A. F., Turgeon, B. L., Houston, L., McIntyre, J. C., Marshall, and D. A., Fergusson. 2013. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. Journal of the American Medical Association 309 (7):678–88. doi:10.1001/jama.2013.430.